Skip to main content

Advantages of MB3D+

 
Publication of a clinical study on the advantages of
Mont-Blanc 3D+ in the treatment of scoliosis
Spineway, specialized in the treatment of severe disorders of the spine, announces the publication of a scientific article in the renowned scientific journal Spine Deformity1 highlighting the benefits of the Mont-Blanc 3D+ technology for the treatment of adolescent idiopathic scoliosis.An international clinical study of 49 patients
This clinical study carried out by Professor Carlos Barrios (Université Catolique de Valencia, Spain) covered four countries and involved post-operative follow-up of an average of 32 months by surgeons Dr. José Lajara (Spain), Dr. Philippe Mazeau (France), Dr. Karen Weissmann (Chile), Dr. Guahua Lu (China), Dr. Bing Wang (China), Dr. Lei Kuang (China), Dr. Yong Hai (China) and Dr. José I. Maruenda (Spain).
This multicentric group provided the clinical data on 49 patients suffering from adolescent idiopathic scoliosis and, in particular, studied the restoration of thoracic kyphosis (curvature in the middle of the spine) in patients after corrective surgery.The article, written by Professor Carlos Barrios, concludes that the use of Spineway’s Mont-Blanc 3D+ instruments provides a better correction of thoracic kyphosis based on vertebral co-planar alignment than the other methods and instruments used for comparison in the study.Restoration of the thoracic spine’s natural curves
Current techniques using pedicle screws have successfully corrected the spinal deformation of scoliosis patients from a “frontal view” without, however, restoring the thoracic spine’s natural curves from a “sagittal view.” These effective alignment methods unfortunately often result in patients having “flat backs.”
The natural thoracic curve plays a part in the body’s overall balance and failure to reconstruct this natural curve creates long-term problems (pain, compensatory deformation in the cervical spine causing vision problems, balance, etc.) that are currently the subject of many publications and communications.The corrective technique provided by Spineway’s Mont-Blanc 3D+ instruments allows for “frontal-view” restoration of a deformed spine as well as “sagittal view” restoration of a patient’s thoracic curve in a way that is controlled by the surgeon. This three-dimensional correction of the vertebrae thus protects the patient from possible long-term adverse effects.Stéphane Le Roux, Chairman and CEO of Spineway, said, “We are happy and proud of this article that is the fruit of collaborative work that began over five years ago with top surgeons specialized in the treatment of scoliosis. The results obtained in these different countries confirm the Group’s ability to offer innovative instruments and implants for the spine. It shows Spineway’s ongoing desire to provide solutions that contribute to the improvement of care for patients with disorders of the spine. I would like to thank all the surgeons who participated in this study for their trust and participation.”This article shows the quality of the Mont Blanc 3D+ instruments developed and patented by Spineway, and the progress this means for patients’ everyday comfort, as well as for the surgeons’ operating technique.Upcoming: 27 October 2020 – 2020 half-year resultsSPINEWAY IS ELIGIBLE FOR THE PEA-PME (EQUITY SAVINGS PLANS FOR SMES)Find out all about Spineway at www.spineway.comThis press release on July 22, 9 am has been prepared in both English and French. In case of discrepancies, the French version shall prevail.Spineway designs, manufactures and markets innovative implants and surgical instruments for treating severe disorders of the spinal column.Spineway has an international network of over 50 independent distributors and 90% of its revenue comes from exports.Spineway, which is eligible for investment through FCPIs (French unit trusts specializing in innovation), has received the OSEO Excellence award since 2011 and has won the Deloitte Fast 50 award (2011). Rhône Alpes INPI Patent Innovation award (2013) – INPI Talent award (2015).ISIN: FR0011398874 – ALSPWContacts:
1https://link.springer.com/article/10.1007%2Fs43390-020-00067-8
AttachmentCP_SPW_MB3D+_VD GB

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.